Atlas Trials

Entecavir to TAF Switch

Clinical trial NCT03489239 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03489239
Sponsor
Thomas Jefferson University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatitis B
Start date
2017-11-16
Primary completion
2020-08-15
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.